Saved Google Search 12/15/2002 . . . courtesy of PsychopharmINFO
Go to Google News Home
News BETA
Preferences    Search Tips 
 
 Web 
 Images 
 Groups 
 Directory 
 News-New! 
Searched news for lexapro. (BETA)  Results 1 - 19 of 19. Search took 0.04 seconds.
   Top Stories
   World
   U.S.
   Business
   Sci/Tech
   Sports
   Entertainment
   Health

About Google News

Sort by relevance   Sorted by date

Did you mean: lexpro  

Drug firms and doctors: the offers pour in
Boston Globe, MA - 13 hours ago
... including Forest Pharmaceuticals, which promised the doctors $500 each for listening
to a Saturday morning talk about the firm's new antidepressant, Lexapro ...

RESEARCH ALERT-UBS Warburg cuts Forest Labs
Forbes - 09 Dec 2002
... CJ Sylvester raised his 2003 earnings per share estimate to $3.65 from $3.52 based
on anticipated strong sales of Forest's antidepressants Celexa and Lexapro ...

Forest, Recordati Shares Dive on Delay
ABC News - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest, Recordati Shares Dive on Delay
Reuters, UK - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest, Recordati Shares Dive on Delay
ABC News - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest, Recordati Shares Dive on Delay
Reuters, UK - 06 Dec 2002
... I wouldn't change my bullish stance on the stock," said JP Morgan analyst Corey
Davis. "The reason you own this thing is for Lexapro and Memantine.". ...

Forest Updates Status of Lercanidipine Regulatory Submission
Newsday - 06 Dec 2002
... Forest’s growing line of products includes: Lexapro(TM), indicated as initial as
well as maintenance treatment of major depressive disorder; Celexa(TM), also ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 25 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 24 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 23 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 22 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 21 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Madison Ave. Plays Growing Role in Drug Research
New York Times - 21 Nov 2002
... how successful the invisible hand of Madison Avenue can be, one need look no further
than the introduction this summer of a new antidepressant called Lexapro ...

Synaptic Agrees to Lundbeck Buyout
ABC News - 21 Nov 2002
... Lundbeck is best known for licensing blockbuster anti-depression drug Celexa
and its successor, Lexapro, to US drugmaker Forest Laboratories Inc. . ...

Synaptic Agrees to Lundbeck Buyout
ABC News - 21 Nov 2002
... Lundbeck is best known for licensing blockbuster anti-depression drug Celexa
and its successor, Lexapro, to US drugmaker Forest Laboratories Inc. . ...

Lundbeck Buys Synaptic for $121 Million
ABC News - 21 Nov 2002
... transaction. Lundbeck is best known for licensing out its anti-depression
drug Lexapro to US drugmaker Forest Laboratories Inc .

Synaptic agrees to Lundbeck buyout for $121 mln
Forbes - 21 Nov 2002
... Lundbeck is best known for licensing out its anti-depression drug Lexapro
to US drugmaker Forest Laboratories Inc (nyse: FRX - news - people).

Johnson & Johnson units to sell Lundbeck's Cipramil , Lexapro in ...
AFX Press - 20 Nov 2002
... an agreement with Janssen-Cilag International, Zug, Switzerland, for the marketing,
sale and distribution of Lundbeck's Cipramil (citalopram) and Lexapro ...

Lundbeck announces strategic alliance to market Cipramil and ...
Pressi.com - 20 Nov 2002
... that it has entered into an agreement with Janssen-Cilag International, Zug, Switzerland,
to promote, sell, and distribute Cipramil (citalopram) and Lexapro ...

Did you mean to search for: lexpro  



Google Home - Advertise with Us - Search Solutions - Services & Tools - Jobs, Press, & Help

©2002 Google